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Abstract
With the explosion in genomic and functional genomics information, methods for disease gene identiﬁcation are rapidly evolving. Databases
are now essential to the process of selecting candidate disease genes. Combining positional information with disease characteristics and
functional information is the usual strategy by which candidate disease genes are selected. Enrichment for candidate disease genes, however,
depends on the skills of the operating researcher. Over the past few years, a number of bioinformatics methods that enrich for the
most likely candidate disease genes have been developed. Such in silico prioritisation methods may further improve by completion of
datasets, by development of standardised ontologies across databases and species and, ultimately, by the integration of different strategies.
Keywords: bioinformatics, candidate disease gene prediction
Introduction
Currently, with the increase in accessible data and the devel-
opment of novel molecular biology techniques, new methods
for the identiﬁcation of disease genes are evolving. Linkage
studies and mutation screening are becoming easier and the
number of identiﬁed (disease) genes is increasing rapidly. 2003
saw the completion of the human genome sequence and the
number of genes is now set to 20,000–25,000.
1,2
With all the
genetics technology in place, identiﬁcation of disease-related
mutations in Mendelian single-gene disorders mainly depends
on having the right patients and families. The genetic analysis
of complex diseases still remains a difﬁcult task, however, and
most genes for multifactorial disease remain to be discovered.
Genetic mapping by linkage is a mainstay of human gen-
etics research. While positional information reduces the
number of genes that are candidates for causing the disease,
this reduction is often not sufﬁcient for rapid disease gene
identiﬁcation.
The aim of candidate gene prioritisation methods is to
choose those genes for detailed mutation analysis that are most
likely to be the cause of the disease. This is especially relevant
since positional methods may leave up to 100 different genes as
candidates. Hence additional information to be used for
prioritisation is essential.
Databases have become a core source for today’s gene
hunters. Retrieval systems such as the National Center for
Biotechnology Information’s Entrez,
3
the Sequence Retrieval
System
4
and Maarten’s Retrieval System
5
provide easy and fast
access to a collection of frequently used databases. The main
focus of these retrieval systems is to fetch a set of database
entries that meet the user query. Identiﬁcation of a disease
gene is most likely to be successful when positional and
functional routes are integrated. Integration of data based on
genomic context, such as in the University of California, Santa
Cruz genome browser and Ensembl,
6,7
resulted in step by step
interfaces (eg EnsMart
8
) which extract data based on chro-
mosomal position, gene expression
9
and gene ontology
(GO).
10
Enrichment for disease candidate genes using these
database interfaces, however, depends heavily on the operation
skills of the researcher. Alternative methods have been
developed systematically to explore datasets for the most likely
candidate disease genes. This paper presents an overview of
such methods and their accessibility.
Candidate disease gene identiﬁcation
methods
The methods developed for candidate disease gene identiﬁ-
cation use different data sources and strategies.
Perez-Iratxeta et al. developed the Genes2Diseases (G2D)
method.
11
This searches Medline abstracts for MeSH-C
(phenotypic features) and MeSH-D (chemical objects)
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terms.
12,13
Co-occurrence of MeSH-C/D in the Medline
abstracts was considered to be related to the association
between the chemical and the phenotypic terms. Sequences in
the Ref Seq database
14
are used to associate MeSH-D from the
sequence Medline links with the GO functional annotation of
the same sequence.
10
This creates the possibility of associating
phenotype terms with functional terms via the chemical terms.
Literature on a disease can be screened for MeSH-C terms,
which are then used to determine the association between the
disease and the genes with the GO annotation. The system
was tested on 450 diseases that had previously been mapped to
a speciﬁc locus but without a particular gene assigned. The
resulting scores were compared with 100 diseases for which
the gene was known.
11
On average, Perez-Iratxeta et al. tested
30-megabase candidate regions. Assuming 20,000–25,000
human genes,
1,2
and an average gene density of one gene per
120 kilobases, an 8–31-fold enrichment was calculated for
this method. The G2D method was recently extended with
expressed sequence tag data. The system for phenotype input
was also improved, which reduces the prior clinical knowledge
required to be entered. This new version of G2D performs
better, mostly because more databases are used with larger
datasets. Both versions of the method are available online
(http://www.bork.embl-heidelberg.de/g2d/; http://www.
ogic.ca/projects/g2d_2/).
Whereas G2D uses information extracted from the medical
literature, POCUS, developed by Turner et al., uses functional,
domain annotation and gene expression data to prioritise can-
didate disease genes.
15
The method assumes that genes involved
in the same disease will share GO annotation, protein domains
and a similar expression pattern. A scoring system that includes
these sources allows one to rank genes in the candidate disease
regions. POCUS seeks over-representation of functional
annotation between loci for the same disease. Larger candidate
regions are a priorimore likely to share similarities and are thus less
likely to generate gene connections that are statistically signiﬁ-
cant. The method was tested with 29 diseases and achieved an
enrichment of 12–42-fold. The method cannot be used online,
but the POCUS scripts can be downloaded.
Speciﬁc gene characteristics have been used in candidate
disease gene identiﬁcation. Sequence analysis of human/
eukaryotic genes showed that human proteins with multiple
long amino acid runs are more often linked with genetic
disease than are shorter proteins.
16
Lopez-Bigas et al. found
that proteins involved in genetic diseases tend to be long,
conserved and without close paralogues.
17
Disease genes are
more frequently found to be conserved in other species, but
this might be due the preferential sequencing of known (dis-
ease) genes. The disease gene prediction system using these
sequence characteristics can be accessed online (http://cgg.ebi.
ac.uk/services/dgp/).
Similarly, Adie et al. tested sequence property analysis using
alternating decision trees.
18
They found differences between
random genes and disease genes based on a number of features,
including: gene/cDNA/protein/3
0
untranslated region length,
the number of exons, distance to the adjacent gene, higher
level of conservation in the mouse, signal peptide encoding
and 5
0
CpG islands. Tests for candidate gene identiﬁcation
showed 2–25-fold enrichment. Data can be accessed using the
PROSPECTR web server (http://www.genetics.med.ed.ac.
uk/prospectr/). The user can rank genes for their likelihood to
be involved in a disease, either from a list or a genomic region.
The method was recently extended with GO terms, Interpro
domains and gene expression data. The SUSPECTS web
server uses PROSPECTR, and allows one to rank genes for
their likelihood of involvement in the disease of interest
(http://www.genetics.med.ed.ac.uk/suspects/). Smith et al.
used a comparable analysis, which found similar differences
between disease and non-disease genes. Using discriminant
analysis, they showed that these differences may help to predict
human disease genes;
19
however, their method is not accessible
online.
It is possible systematically to interrogate the multitude of
gene and protein expression data that are produced by
methods such as RNA expression microarray analysis and
SAGE. For example, Tifﬁn et al. developed a method which
uses an anatomical ontology (eVOC)
9
to integrate biomedical
literature and human gene expression data.
20
The method uses
eVOC as a controlled vocabulary to ﬁnd anatomy terms
speciﬁc for the disease in PubMed abstracts. The anatomy
terms are ranked and the candidate genes are selected using the
highest ranked terms. The selected candidate genes have a
gene expression pattern that matches the disease associated/
affected tissues. The enrichment reached is 1.5–3.0-fold and
the correct gene was found in more than 85 per cent of the
cases. Data and scripts are available, but there is no web
interface (http://www.sanbi.ac.za/tifﬁn_et_al/).
The link between the tissues and organs that are affected by
a genetic disease and candidate gene expression proﬁles have
been exploited.
21,22
GeneSeeker uses human as well as mouse
expression and phenotypic data stored in various databases
(http://www.cmbi.ru.nl/GeneSeeker/). This information is
combined with positional data for the genes from both species.
The system uses different online databases rather than local
data and thus mines in real-time. The GeneSeeker approach
differs from the other candidate prioritisation approaches by
utilising cross-species data. Knowledge of model organisms
makes comparative candidate gene selection possible. This
situation applies when a gene is known to cause a similar
phenotype in another species. Nonetheless, a direct compari-
son between the phenotypes in humans and model organisms
can be complicated because of differences in anatomy. Transfer
of knowledge by phenotype is most straightforward in other
mammalian species, such as the mouse, that are evolutionarily
close to humans. An example is the disease gene identiﬁcation
in ectrodactyly-ectodermal dysplasia-clefting syndrome. This
human disease gene was identiﬁed by a comparable phenotype
in homozygous null mice.
23
A 7–25-fold enrichment of
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candidate disease genes was achieved using GeneSeeker on a
test set of ten diseases.
21
Recently, Bradford et al. presented a
cross-species search system.
24
The human–mouse gene
searcher enables the user to search with phenotype data from
human and mouse and links this to the Mouse Gene
Expression Database.
25
This tool can assist in the human–
mouse phenotype mapping process. It has its own merits, and
can also be implemented in GeneSeeker.
A number of groups have started to use clinical overlap
between genetic diseases to cluster phenotypes, thereby
allowing correlations with the functional classiﬁcation of their
underlying disease genes.
26
Such phenotype relationships
might be a powerful method for function prediction.
27–29
The human phenotype collection and the underlying gene–
phenotype relations can therefore be used as a tool for
functional genomics.
30
Freudenberg and Propping developed a method for
clustering genetic diseases based on their phenotype
similarity.
31
They manually attributed the disease phenotypic
manifestations using the Online Mendelian Inheritance in
Man (OMIM) database.
32
A similarity measure was developed
to compare the phenotypes and to perform a complete linkage
clustering. The approach was tested with a leave-one-out
cross-validation of 878 diseases from the OMIM database,
using 10672 candidate genes from the human genome. They
achieved an enrichment of 7–33-fold. Unfortunately, the
method is not available for other users.
Similarly, Cantor et al. clustered OMIM
32
records based on
the clinical synopsis section.
33
They reduced the disease
characteristics to 50 categories. In a test of two diseases, they
found relationships at the genotype level. Since the authors
only intended to establish proof of principle on using OMIM
for phenotype clustering, they did not systematically analyse
phenotype–genotype relationships, and their system cannot be
accessed directly.
Masseroli et al. developed the GFINDer system. This web
tool allows one to mine the annotation information from
several databases for a given set of sequence identiﬁers.
34
Filter
parameters are set manually in the system to select disease
genes, and statistical analysis can be performed. Recently, the
clinical synopsis of OMIM was integrated into the GFINDer
system (http://www.bioinformatics.polimi.it/GFINDer/).
Phenotype data were normalised and structured in order to
obtain two controlled vocabularies suitable for computational
purposes. The absence of a predeﬁned strategy makes the
efﬁciency of the system heavily dependent on the operating
researcher. The authors presented only a few selected examples
of their method, which makes it difﬁcult to estimate the
enrichment.
34
van Driel et al. devised a method for comparing phenotypes
derived from the OMIM database that uses a textual similarity
measure by an automated full text-analysis technique, rather
than predeﬁned term classes, and analysed the phenotype–
genotype relationships.
35
They found that phenotype
similarity scores, which are based on automatic quantiﬁcation,
correlate positively with a number of measures of gene func-
tion, including protein sequence, similarity of shared protein
motifs, functional annotation and direct protein–protein
interaction. The data support the idea that phenotypic
relationships may be used as indicators of biological and
functional interactions at the gene and protein levels. The
phenotype–phenotype ranking scores can be searched online
(http://www.cmbi.ru.nl/MimMiner/). The method can be
used to study the phenotypic relationships at the genotype
level, by which the phenotype becomes a tool for functional
genomics.
30
The aim was not to enrich a speciﬁc region for
candidate genes, but the data can be used for this purpose.
Future: Integration and
standardisation
The various methods for identifying my candidate disease
genes in humans cover different concepts. They use functional
and literature data, gene-speciﬁc characteristics, anatomy-
based gene/protein expression data or phenotype comparison
analyses. In light of the comparable enrichment levels achieved
with the different methods, it is likely that they can comp-
lement each other.
The results discussed here suggest that the phenotype is a
powerful source for revealing biological function and that
special attention is needed for the standardisation of the
description of phenotypes.
30
Various approaches to a more
systematic description of phenotype data have been proposed
and await further development.
36,37
Essential to the improve-
ment of the candidate disease gene identiﬁcation methods will
be the establishing of standard vocabularies that can be used
across databases and species. A further challenge will be to
develop, reﬁne and integrate these methods into a system that
aids in elucidation and understanding of the mechanisms of
(complex) disease.
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